Rare diseases
Investigational molecules
Locations
1125 Trenton Harbourton Rd, 08560-1504, United States
Clinical research includes therapies for generalized anxiety disorder, with studies examining treatment options for patients who have had an inadequate response to existing care. The portfolio also covers both standalone and adjunctive approaches for anxiety symptoms.
Work in this area reflects a focus on psychiatric treatment for persistent anxiety symptoms and response-limited patient populations.
Intra-Cellular Therapies Inc. runs clinical trials in conditions such as Generalised anxiety disorder, Dementia Alzheimer's type, Bipolar disorder, Psychotic disorder, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Study on ITI-1284 for Patients with Generalized Anxiety Disorder Who Did Not Respond Well to Previous Treatments
BulgariaStudy on ITI-1284 for Treating Agitation in Alzheimer's Patients
BulgariaStudy on ITI-1284 for Treating Psychosis in Alzheimer's Patients
BulgariaStudy on ITI-1284 for Patients with Generalized Anxiety Disorder Not Responding to Current Treatment
BulgariaStudy on Lumateperone for Patients with Major Depressive Disorder Not Responding to Antidepressants
BulgariaStudy on Lumateperone for Treating Manic Episodes in Bipolar I Disorder Patients
BulgariaStudy on Lumateperone for Treating Manic Episodes in Bipolar I Disorder Patients
BulgariaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
